Basal cell carcinoma of skin of unspecified lower limb, including hip
ICD-10 C44.711 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of unspecified lower limb, including hip.
Basal cell carcinoma (BCC) is the most common form of skin cancer, arising from the basal cells in the epidermis. This malignancy is typically associated with prolonged sun exposure, leading to DNA damage in skin cells. BCCs are characterized by their slow growth and low metastatic potential, making them less aggressive than other skin cancers. The unspecified lower limb, including the hip, indicates that the exact location of the carcinoma is not specified, which can complicate treatment planning. Surgical excision is the primary treatment modality, with the goal of achieving clear surgical margins to minimize recurrence. Reconstruction may be necessary depending on the size and location of the excised tumor, particularly in cosmetically sensitive areas. The prognosis for BCC is generally favorable, with a high cure rate when detected early and treated appropriately. However, patients with a history of skin cancer or significant sun exposure should be monitored regularly for new lesions.
Detailed descriptions of the lesion, including size, location, and histological findings.
Diagnosis and treatment of BCC, including Mohs micrographic surgery.
Documentation of prior skin cancers and family history of skin malignancies.
Comprehensive treatment plans and follow-up care documentation.
Management of recurrent BCC and coordination of care with dermatology.
Consideration of systemic therapies for high-risk BCC patients.
Used when excising a BCC from the lower limb.
Document the size of the lesion and margins excised.
Dermatology may require additional notes on the histology.
The primary treatment for basal cell carcinoma is surgical excision, often with Mohs micrographic surgery for high-risk areas to ensure clear margins.
